Involvement of SPARC and MMP-3 in the pathogenesis of human pterygium

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 2, 2012, Pages 587-595

  Seet, Li Fong ^a,b   Tong, Louis ^a,c,d   Su, Roseline ^a   Wong, Tina T ^a,b,c,e  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; OSTEONECTIN; SCLEROPROTEIN; STROMELYSIN;

ARTICLE; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PTERYGIUM; REAL TIME POLYMERASE CHAIN REACTION; STROMA; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE;

BLOTTING, WESTERN; CELLS, CULTURED; CONJUNCTIVA; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATRIX METALLOPROTEINASE 3; OSTEONECTIN; PHENOTYPE; PTERYGIUM; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84858955221     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7941     Document Type: Article

References (33)

1. Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999;6:219-228.
2. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf. 2008;6:24-43.
3. Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003; 48:145-180.
4. John-Aryankalayil M, Dushku N, Jaworski CJ, et al. Microarray and protein analysis of human pterygium. Mol Vis. 2006;12:55-64.
5. Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retinal Eye Res. 2004;23:195-228.
6. Nagase H, Woessener, JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
7. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007; 8:221-233.
8. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94:815-820.
9. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161-174.
10. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest. 2001;107:1049-1054.
11. Bradshaw AD. The role of SPARC in extracellular matrix assembly. J Cell Commun Signal. 2009;3:239-246.
12. Seet LF, Su R, Barathi VA, et al. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS One. 2010;5:e9415.
13. Chlenski A, Cohn SL. Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol. 2010;21:55-65.
14. Tremble PM, Lane TF, Sage EH, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts. J Cell Biol. 1993; 121:1433-1444.
15. Gilles C, Bassuk JA, Pulyaeva H, et al. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res. 1998;58:5529-5536.
16. McClung HM, Thomas SL, Osenkowski P, et al. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of Galectin-3 in U87MG glioma cells. Neurosci Lett. 2007; 419:172-177.
17. Tong L, Chew J, Yang H, et al. Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data. BMC Med Genomics. 2009;2:14.
18. Wong YW, Chew J, Yang H, et al. Expression of insulin-like growth factor binding protein-3 in pterygium tissue. Br J Ophthalmol. 2006;90:769-772.
19. Villone D, Fritsch A, Koch M, et al. Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly binds to banded collagen fibrils. J Biol Chem. 2008;283: 24506-24513.
20. Reber F, Gersch U, Funk RW. Blockers of carbonic anhydrase can cause increase of retinal capillary diameter, decrease of extracellular and increase of intracellular pH in rat retinal organ culture. Graefe's Arch Clin Exp Ophthalmol. 2003;241:140-148.
21. Zajicek G, Perry A, Pe'er J. Streaming of labelled cells in the conjunctival epithelium. Cell Prolif. 1995;28:235-243.
22. Rosellini A, Papini S, Giannarini C, Nardi M, Revoltella RP. Human conjunctival epithelial precursor cells and their progeny in 3D organotypic culture. Int J Dev Biol. 2007;51:739-743.
23. Yu HM, Frank DE, Zhang J, et al. Basal prostate epithelial cells stimulate the migration of prostate cancer cells. Mol Carcinog. 2004;41:85-97.
24. Pajoohesh-Ganji A, Stepp MA. In search of markers for the stem cells of the corneal epithelium. Biol Cell. 2005;97:265-276.
25. Aycock RL, Bradshaw AC, Sage EH, Starcher B. Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC. J Invest Dermatol. 2004;123:592-599.
26. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 2001;19:816-827.
27. Iruela-Arispe ML, Lane TF, Redmond D, et al. Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol Biol Cell. 1995;6: 327-343.
28. Koukourakis MI, Giatromanolaki A, Brekken RA, et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res. 2003; 63:5376-5380.
29. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14:608-616.
30. Goldblum SE, Ding X, Funk SE, Sage EH. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA. 1994;91:3448-3452.
31. Zitka O, Kukacka J, Krizkova S, et al. Matrix metalloproteinases. Curr Med Chem. 2010;17:3751-3768.
32. Li DQ, Lee SB, Gunja-Smith Z, et al. Overexpression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol. 2001;119:71-80.
33. Sage EH, Reed M, Funk SE, et al. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem. 2003;278:37849-37857.